Hypercholesterolemia clinical trials
21 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Alirocumab in Patients on a Stable Dialysis Regimen
- Intermittent Hypoxia-initiated Plasticity in Humans: A Multi-pronged Therapeutic Approach to Treat Sleep Apnea and Overlapping Co-morbidities
- A Safety and Tolerability Trial Evaluating CTX310 in Participants With Refractory Dyslipidemias
- Healthy Living Anson Study
- A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Phase 1b Study of VERVE-201 in Patients With Refractory Hyperlipidemia
- Causes and Natural History of Dyslipidemias
- A Randomized Control Trial of Conversations Advancing Resilience and Empowerment (CARE) Intervention
- Assessing the Effects of Corn and Avocado Oils on the Cardiometabolic Risk Factor Profile
- Mechanism of Ketogenic Diet-Induced Hypercholesterolemia
- Pharmacogenomic Informed Statin Prescribing
- Impact of the Corrie Lipids Digital Health Program on Lipid Optimization
- Natural Heart Health Supplement Trial
- Vascular Intervention Strategies Trial for Alzheimer's
- Long-term Efficacy and Safety of OLE LIB003 in HoFH, HeFH, and High-risk CVD Patients Requiring Further LDL-C Reduction
- Improving Lipid Optimization Quality and Treatment Options in ASCVD
- Virtual Lifestyle Intervention for Weight Management and Cardiovascular Heal
- Testing the Impact of Pre-visit Priming for Medications
- Promoting Nutrition Security and Chronic Disease Management Through a Produce Prescription Program
- Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hypercholesterolemia” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.